IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 3420 
Small font sizeDefault font sizeIncrease font size
Navigate Here
 »   Next article
 »   Previous article
 »   Table of Contents

Resource Links
 »   Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 »Related articles
 »   Citation Manager
 »   Access Statistics
 »   Reader Comments
 »   Email Alert *
 »   Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded95    
    Comments [Add]    
    Cited by others 2    

Recommend this journal


Year : 2013  |  Volume : 45  |  Issue : 6  |  Page : 631-633

Pott's disease and hypercalcemia in a patient with rheumatoid arthritis receiving methotrexate monotherapy

1 Internal Medicine Clinic, Bezmialem Vakif University, Faculty of Medicine, Fatih, Istanbul 34093, Turkey
2 Family Medicine Clinic, Recep Tayyip Erdogan University, Faculty of Medicine, 53100 Rize, Turkey

Correspondence Address:
Mehmet Zorlu
Internal Medicine Clinic, Bezmialem Vakif University, Faculty of Medicine, Fatih, Istanbul 34093
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0253-7613.121385

Rights and Permissions

Methotrexate (MTX) may have adverse effects on multiple organs and system. A few cases of pulmonary tuberculosis in-patients with rheumatoid arthritis (RA) while receiving MTX monotherapy has been reported in the literature. We submit a case of vertebral tuberculosis with hypercalcemia in a patient receiving MTX monotherapy. Patient with RA taking MTX for 15 years developed pancytopenia, skin necrosis, tuberculous spondylodiscitis and hypercalcemia. The present case showed adverse effects of MTX therapy may occur even after years of continuous treatment. Due to pancytopenia in older patients, life-threatening tuberculosis at unusual sites may develop.


Print this article     Email this article

Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer | Privacy Notice
Online since 20th July '04
Published by Wolters Kluwer - Medknow